Sterile Drug Products by Unique Pharmaceuticals Ltd.: Recall - Lack of Sterility Assurance
Administration of a non-sterile drug product intended to be sterile may result in serious and potentially life-threatening infections or death.
Italiano
Administration of a non-sterile drug product intended to be sterile may result in serious and potentially life-threatening infections or death.
Voluntary Nationwide Recall Of One Lot. Intravenous administration of a non-sterile product can result in infections that may be life-threatening, and may result in prolonged hospitalization or organ failure.
Il Comitato di Valutazione del Rischio per la Farmacovigilanza (Pharmacovigilance Risk Assessment Committee, PRAC) raccomanda la restrizione dell’uso di bromocriptina per bloccare la produzione di latte materno.
Il Comitato di Valutazione del Rischio per la Farmacovigilanza (Pharmacovigilance Risk Assessment Committee, PRAC) raccomanda la sospensione dal mercato delle soluzioni orali di metadone contenenti povidone ad alto peso molecolare.
May present significant risk for patients with history of CAD, CHF, arrhythmias, or stroke.
May interact, in life-threatening ways, with other medications.
80.211.154.110